| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Quanren He | Q116005078 |
| P2093 | author name string | Valentino J Stella | |
| P2860 | cites work | Sucralose--an overview of the toxicity data | Q30601104 |
| Synthesis and characterization of water-soluble hydroxybutenyl cyclomaltooligosaccharides (cyclodextrins). | Q31042181 | ||
| Gastrointestinal tolerance of gamma-cyclodextrin in humans | Q33421441 | ||
| Itraconazole in cyclodextrin solution | Q33637258 | ||
| Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features | Q33779363 | ||
| Mechanisms of drug release from cyclodextrin complexes | Q33933388 | ||
| Cyclodextrins in ophthalmic drug delivery | Q33933395 | ||
| Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. | Q33980029 | ||
| Intravenous itraconazole | Q34284268 | ||
| Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation | Q34417057 | ||
| 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review | Q34433951 | ||
| Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships | Q34522512 | ||
| Cyclodextrins in drug delivery: an updated review | Q34563402 | ||
| Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-beta-cyclodextrin | Q36774562 | ||
| Subchronic intravenous toxicity studies with gamma-cyclodextrin in rats. | Q36897658 | ||
| Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens | Q39652421 | ||
| Cyclodextrin-induced apoptosis in human keratinocytes is caspase-8 dependent and accompanied by mitochondrial cytochrome c release | Q40227433 | ||
| Cyclodextrins: their future in drug formulation and delivery | Q40895926 | ||
| The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. | Q41181635 | ||
| Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization | Q41192883 | ||
| Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery | Q41219657 | ||
| A toxicological review of lactose to support clinical administration by inhalation | Q41596368 | ||
| Cyclodextrin derivatives in pharmaceutics | Q41720751 | ||
| The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent | Q42022417 | ||
| Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema | Q42274442 | ||
| Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins | Q42282834 | ||
| Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD. | Q43682884 | ||
| Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability | Q44120619 | ||
| Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro | Q44179394 | ||
| Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution | Q44593119 | ||
| Subchronic oral toxicity studies with alpha-cyclodextrin in rats. | Q44987107 | ||
| Subchronic (13-week) oral toxicity study of alpha-cyclodextrin in dogs | Q44987110 | ||
| Embryotoxicity and teratogenicity study with alpha-cyclodextrin in rats | Q44987114 | ||
| Embryotoxicity and teratogenicity study with alpha-cyclodextrin in rabbits | Q44987116 | ||
| Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats | Q44987122 | ||
| In vitro and in vivo evaluation of a sulfobutyl ether beta-cyclodextrin enabled etomidate formulation | Q45045545 | ||
| A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection | Q45754321 | ||
| Intravenous voriconazole therapy in a preterm infant | Q46520649 | ||
| The binding interaction of synthetic ozonide antimalarials with natural and modified beta-cyclodextrins | Q46825685 | ||
| Alteration of the intravenous pharmacokinetics of a synthetic ozonide antimalarial in the presence of a modified cyclodextrin | Q46865806 | ||
| Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol | Q48223026 | ||
| Safety of parenteral hydroxypropyl beta-cyclodextrin | Q49182103 | ||
| Subchronic oral toxicity studies with gamma-cyclodextrin in rats. | Q50875478 | ||
| Embryotoxicity and teratogenicity study with gamma-cyclodextrin in rabbits. | Q50875482 | ||
| The reproductive and developmental toxicity profile of beta-cyclodextrin in rodents. | Q52207608 | ||
| Combined effect of complexation and pH on solubilization. | Q52219437 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 30-42 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Toxicologic Pathology | Q7830407 |
| P1476 | title | Cyclodextrins. | |
| P478 | volume | 36 |
| Q42148881 | 2-Hydroxypropyl-beta-cyclodextrin removes all-trans retinol from frog rod photoreceptors in a concentration-dependent manner |
| Q59011531 | 2-[3,5-Bis-(2-fluorobenzylidene)-4-piperidon-1-yl]-N-(4-fluorobenzyl)-acetamide and Its Evaluation as an Anticancer Agent |
| Q24598867 | 2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease |
| Q36259762 | A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs |
| Q89860803 | A Mixed Micellar Formulation for the Transdermal Delivery of an Indirubin Analog |
| Q36041427 | A Phase 1c Trial Comparing the Efficacy and Safety of a New Aqueous Formulation of Alphaxalone with Propofol |
| Q47911443 | A molecular dynamics study of conformations of beta-cyclodextrin and its eight derivatives in four different solvents. |
| Q39399409 | A novel triterpene extract from mistletoe induces rapid apoptosis in murine B16.F10 melanoma cells |
| Q57798886 | A therapeutic approach to pantothenate kinase associated neurodegeneration |
| Q36665183 | Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors |
| Q35295935 | Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation |
| Q101131575 | Affinity-based polymers provide long-term immunotherapeutic drug delivery across particle size ranges optimal for macrophage targeting |
| Q29543246 | Affinity‐Based Drug Delivery |
| Q38653600 | Alfaxalone alone or combined with midazolam or ketamine in dogs: intubation dose and select physiologic effects |
| Q38946033 | Alkylene-bridged viologen dendrimers: versatile cell delivery tools with biosensing properties |
| Q35650967 | Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease |
| Q37979244 | Amiodarone (Nexterone) injection for the treatment and prophylaxis of frequently recurring ventricular fibrillation |
| Q34068720 | Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. |
| Q27683870 | Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones |
| Q42831961 | Assessment of Hydroxypropyl Methylcellulose, Propylene Glycol, Polysorbate 80, and Hydroxypropyl‐β‐Cyclodextrin for use in developmental and reproductive toxicology studies |
| Q37733170 | Assessment of antioxidant activity of spray dried extracts of Psidium guajava leaves by DPPH and chemiluminescence inhibition in human neutrophils. |
| Q58484641 | Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications |
| Q58626026 | C60@lysozyme: a new photosensitizing agent for photodynamic therapy |
| Q60981783 | Captisol®: an efficient carrier and solubilizing agent for essential oils and their components |
| Q38810056 | Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy |
| Q56769197 | Cholesterol Modification of (Bio)Polymers Using UV-Vis Traceable Chemistry in Aqueous Solutions |
| Q55385725 | Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. |
| Q27681888 | Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication |
| Q27006029 | Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease |
| Q36696647 | Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy |
| Q33905993 | Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles |
| Q30570482 | Combinatorial biosynthesis of sapogenins and saponins in Saccharomyces cerevisiae using a C-16α hydroxylase from Bupleurum falcatum |
| Q38539416 | Considerations regarding use of solvents in in vitro cell based assays |
| Q35070666 | Conversion of exogenous cholesterol into glycoalkaloids in potato shoots, using two methods for sterol solubilisation |
| Q38601679 | Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation |
| Q91031521 | Cyclodextrin Reduces Intravenous Toxicity of a Model Compound |
| Q57208363 | Cyclodextrin complexes: Perspective from drug delivery and formulation |
| Q50711738 | Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation. |
| Q34980556 | Cyclodextrin derivatives as anti-infectives |
| Q48368555 | Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice |
| Q36302736 | Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream. |
| Q37251166 | Cyclodextrin protects podocytes in diabetic kidney disease |
| Q64218936 | Cyclodextrin-Based Porous Nanocapsules |
| Q46256722 | Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk |
| Q37760218 | Cyclodextrins for drug delivery |
| Q45182744 | Cyclodextrins improve oral absorption of a novel factor Xa inhibitor by interfering with interaction between the drug and bile acids in rats |
| Q47609264 | Cyclodextrins improving the physicochemical and pharmacological properties of antidepressant drugs: a patent review |
| Q100697603 | Cyclodextrins in parenteral formulations |
| Q38470635 | Cyclodextrins: improving the therapeutic response of analgesic drugs: a patent review. |
| Q64277514 | Cyclodextrin⁻Drug Inclusion Complexes: In Vivo and In Vitro Approaches |
| Q38731063 | Cytocompatibility testing of cyclodextrin-functionalized antimicrobial textiles-a comprehensive approach |
| Q54969934 | Deconstructing Signaling Pathways in Cancer for Optimizing Cancer Combination Therapies. |
| Q38750375 | Development of a liquid formulation of poorly water-soluble isosteviol sodium using the co-solvent technology |
| Q39756783 | Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices |
| Q100733191 | Dexamethasone sodium phosphate loaded modified cyclodextrin based nanoparticles: An efficient treatment for Rheumatoid Arthritis |
| Q38769824 | Docetaxel-Loaded Nanoparticles Assembled from β-Cyclodextrin/Calixarene Giant Surfactants: Physicochemical Properties and Cytotoxic Effect in Prostate Cancer and Glioblastoma Cells |
| Q41332041 | Dynamic Mechano-Regulation of Myoblast Cells on Supramolecular Hydrogels Cross-Linked by Reversible Host-Guest Interactions |
| Q41866030 | Effect of complexation with arabinogalactan on pharmacokinetics of "guest" drugs in rats: for example, warfarin. |
| Q34325015 | Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy |
| Q35609223 | Effects of Selected Anionic β-Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats |
| Q35597034 | Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients. |
| Q26768705 | Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data |
| Q28834418 | Efficacy and ototoxicity of different cyclodextrins in Niemann-Pick C disease |
| Q41477504 | Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug |
| Q61813789 | Electrospinning of Cyclodextrin Functional Nanofibers for Drug Delivery Applications |
| Q46156942 | Elucidation of the complexation mechanism between (+)-usnic acid and cyclodextrins studied by isothermal titration calorimetry and phase-solubility diagram experiments. |
| Q47852767 | Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method |
| Q38544457 | Enhanced analgesic activity by cyclodextrins - a systematic review and meta-analysis. |
| Q39417242 | Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration |
| Q34663873 | Enhanced human tissue microdialysis using hydroxypropyl-ß-cyclodextrin as molecular carrier. |
| Q33873730 | Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected] |
| Q42926546 | Enhancement of the Aqueous Solubility and Masking the Bitter Taste of Famotidine Using Drug/SBE-β-CyD/Povidone K30 Complexation Approach |
| Q41880824 | Evaluation of in vitro toxicity of peptide (N-acetyl-Leu-Gly-Leu-COOH)-substituted-β-cyclodextrin derivative, a novel drug carrier, in PC-12 cells |
| Q38819522 | Evaluation of the Cytotoxicity of α-Cyclodextrin Derivatives on the Caco-2 Cell Line and Human Erythrocytes. |
| Q37424588 | Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. |
| Q90771658 | Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations |
| Q92896161 | Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation |
| Q90185529 | Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter |
| Q43553629 | Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog. |
| Q54877897 | Improved activity of β-cyclodextrin glycosyltransferase from Bacillus sp. N-227 via mutagenesis of the conserved residues. |
| Q86408596 | In vivo toxicology of excipients commonly employed in drug discovery in rats |
| Q38136725 | In-vitro prediction of bioavailability following extravascular injection of poorly soluble drugs: an insight into clinical failure and the role of delivery systems |
| Q30317615 | Inhibition of cardiac pacemaker channel hHCN2 depends on intercalation of lipopolysaccharide into channel-containing membrane microdomains |
| Q38246043 | Insights on novel particulate self-assembled drug delivery beads based on partial inclusion complexes between triglycerides and cyclodextrins |
| Q37587802 | Interactions between cyclodextrins and cellular components: Towards greener medical applications? |
| Q92043792 | Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis |
| Q39034201 | Label-free imaging of drug distribution and metabolism in colon cancer cells by Raman microscopy |
| Q35285568 | Lipid biology of the podocyte--new perspectives offer new opportunities |
| Q90194149 | Matryoshka-Type Liposomes Offer the Improved Delivery of Temoporfin to Tumor Spheroids |
| Q87231920 | Methods to evaluate and improve the injection site tolerability of intravenous formulations prior to first-in-human testing |
| Q35273298 | Methyl-β-cyclodextrin up-regulates collagen I expression in chronologically-aged skin via its anti-caveolin-1 activity |
| Q38058809 | Micro and nanosystems for delivering local anesthetics. |
| Q38316288 | Model predicting impact of complexation with cyclodextrins on oral absorption |
| Q40222973 | Molecular Inclusion Complexes of β-Cyclodextrin Derivatives Enhance Aqueous Solubility and Cellular Internalization of Paclitaxel: Preformulation and In vitro Assessments |
| Q27333699 | Molecular mechanism of cyclodextrin mediated cholesterol extraction |
| Q41469153 | Molecular recognition of N-acetyltryptophan enantiomers by β-cyclodextrin. |
| Q53686702 | Nanostructured surfaces for analysis of anticancer drug and cell diagnosis based on electrochemical and SERS tools. |
| Q46393407 | Nimodipine Ophthalmic Formulations for Management of Glaucoma |
| Q37976848 | Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases |
| Q43073039 | Oligodendroglial process formation is differentially affected by modulating the intra- and extracellular cholesterol content |
| Q42854119 | Oral bioavailability of a poorly aqueous drug from three different SBE7-β-cyclodextrin based formulations in beagle dogs |
| Q39533415 | PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH). |
| Q37674638 | PM101: intravenous amiodarone formulation changes can improve medication safety |
| Q41898234 | Parenteral delivery of HPβCD: effects on drug-HSA binding |
| Q90227388 | Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin |
| Q48692030 | Pharmacokinetics of 16-dehydropregnenolone hydroxypropyl-β-cyclodextrin inclusion complex following peroral administration |
| Q38522903 | Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes |
| Q27023475 | Piroxicam-β-cyclodextrin: a GI safer piroxicam |
| Q39064107 | Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy |
| Q37375593 | Preclinical Studies of a Kidney Safe Iodinated Contrast Agent |
| Q33986035 | Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins |
| Q34413196 | Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan |
| Q34515873 | Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes |
| Q37766607 | Promising complexes of acetazolamide for topical ocular administration |
| Q96131891 | Pterostilbene complexed with cyclodextrin exerts antimicrobial and anti-inflammatory effects |
| Q92480577 | Ready-to-use parenteral amiodarone: a feasibility study towards a long-term stable product formulation |
| Q38534300 | Recent advances in cyclodextrin delivery techniques |
| Q37579215 | Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients. |
| Q36043162 | Regulation of presynaptic strength by controlling Ca2+ channel mobility: effects of cholesterol depletion on release at the cone ribbon synapse |
| Q37587698 | Remote loading of preencapsulated drugs into stealth liposomes |
| Q47158453 | Re‐evaluation of β‐cyclodextrin (E 459) as a food additive |
| Q88292893 | Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems |
| Q39119057 | S-nitroso-β-cyclodextrins as new bimodal carriers: preparation, detailed characterization, nitric-oxide release, and molecular encapsulation |
| Q37680577 | Safety of an IV formulation of carbamazepine |
| Q42913787 | Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study |
| Q89879617 | Solid γ-Cyclodextrin Inclusion Compound with Gingerols, a Multi-Component Guest: Preparation, Properties and Application in Yogurt |
| Q92542555 | Structural Design, Synthesis, and Preliminary Biological Evaluation of Novel Dihomooxacalix[4]arene-Based Anti-tumor Agents |
| Q57355314 | Study of the interaction between modified cyclodextrin and octopriox : potential applications in drug delivery |
| Q29036737 | Sugammadex |
| Q94589009 | Sulfobutylether-β-cyclodextrin |
| Q38109100 | Supramolecular complexations of natural products. |
| Q38354545 | Supramolecular cyclodextrin-based drug nanocarriers. |
| Q33862942 | Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids |
| Q38816763 | Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosis |
| Q47241038 | The Role of GABA Receptor Agonists in Anesthesia and Sedation |
| Q38219186 | The bioactivity and toxicological actions of carvacrol |
| Q42470053 | The cholesterol-lowering agent methyl-β-cyclodextrin promotes glucose uptake via GLUT4 in adult muscle fibers and reduces insulin resistance in obese mice |
| Q39346349 | The role of cholesterol-sphingomyelin membrane nanodomains in the stability of intercellular membrane nanotubes |
| Q42101900 | Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment. |
| Q38602715 | Thermodynamics and molecular insight in guest-host complexes of fluoroquinolones with β-cyclodextrin derivatives, as revealed by ATR-FTIR spectroscopy and molecular modeling experiments |
| Q38693012 | Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility |
| Q28473864 | Toxicology and drug delivery by cucurbit[n]uril type molecular containers |
| Q38215673 | Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development |
| Q43063244 | Use of cyclodextrins in biotransformation reactions with cell cultures of Morus nigra: biosynthesis of prenylated chalcone isocordoin |
| Q38671159 | Vehicle Systems and Excipients Used in Minipig Drug Development Studies |
| Q92760736 | Water inside β-cyclodextrin cavity: amount, stability and mechanism of binding |
| Q36184055 | Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice |
| Q50242308 | β-Cyclodextrin duplexes that are connected through two disulfide bonds: potent hosts for the complexation of organic molecules |
| Q34116075 | β-Cyclodextrin/glycyrrhizic acid functionalised quantum dots selectively enter hepatic cells and induce apoptosis |
| Q58582633 | γ-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling |
Search more.